Related Experiment Video
Updated: Aug 18, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
Lipid islands in the gastric mucosa after resection for benign ulcer disease
Abstract:
Lipid islands in the gastric mucosa are macroscopically well demarcated white or yellow-white patches, microscopically composed of accumulations of lipid-filled macrophages. The occurrence of lipid islands has not previously been linked to gastric surgery. This study presents the prevalence of lipid islands after Billroth I and Billroth II resection as well as in a nonoperated control group. Gastroscopy and multiple biopsies were performed at selected intervals after surgery. The occurrence of single or multiple lipid islands increased with the postoperative time, independent of the original ulcer disease or the type of operation performed. In nonoperated patients, lipid islands were found in 6.3%, and approximately the same prevalence was found 1 to 3 years after gastric surgery. A much higher prevalence was found 10 to 15 years postoperatively, and 23 years after Billroth II resection 60% of the patients demonstrated lipid islands. At repeated gastroscopic examinations over a period of 1 to 2 years, no certain changes in number, size, or distribution of the lipid islands were seen. The etiology of lipid islands is unknown, but intestinal-gastric reflux may be the most plausible etiological factor.
More Related Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
04:08Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease